Werewolf Therapeutics (HOWL) Proxy Filing summary

Voting matters and shareholder proposals

• Election of three Class I directors for three-year terms expiring at the 2028 Annual Meeting of Shareholders.

• Ratification of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2025.

• Additional business may be addressed if properly brought before the meeting or any adjournment.

Board of directors and corporate governance

• Nominees for Class I director positions are Briggs Morrison, M.D., Michael Sherman, M.B.A., and Anil Singhal, Ph.D.

Audit committee and external auditor matters

• Proposal to ratify Ernst & Young LLP as the independent registered public accounting firm for the upcoming fiscal year.